How Gilead’s Pharmaceutical Development and Manufacturing Team Delivers Transformative Medicines
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Details
News Market Reaction – GILD
The recorded move for GILD in the trading session of this news was +0.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTHAMPTON, MA / ACCESSWIRE / August 23, 2023 / Gilead Sciences
When Stacey Ma was a little girl, her dream was to work with patients as a doctor. "As it turns out, I became an engineer who makes medicine to help patients," says Stacey, who joined Gilead last summer to lead the Pharmaceutical Development and Manufacturing (PDM) team as Executive Vice President.
Stacey oversees a group that's deeply involved in every stage of the process of creating a new medicine. At the earliest stage, PDM's formulation scientists, process chemists and bioengineers look at a drug candidate and determine such things as whether it can be absorbed by patients or survive being transported and stored and made in sufficient quantities.
If an experimental medicine makes it to the clinical trial stage, PDM teams work to ensure an adequate and high-quality supply. They play a key role in supporting regulatory filings. And if a product is approved, PDM is responsible for delivering an uninterrupted supply of high-quality medicine to people around the world.
"It's not easy to actually innovate a new medicine," says Stacey. "It takes all the different disciplinary expertise to come together - and PDM is one area of that."
As Stacey shares in the video above, Gilead has a long history of strength and speed in PDM. Her team partners closely with Research, Development, Commercial and other functions across the organization to ultimately deliver medicines to people living with some of the world's most devastating diseases.
"PDM is part of Gilead's success because of its innovation in creating manufacturing technology that delivers our transformative medicines as quickly as possible to patients," she says.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View source version on accesswire.com:
https://www.accesswire.com/776263/How-Gileads-Pharmaceutical-Development-and-Manufacturing-Team-Delivers-Transformative-Medicines